Nontuberculous Mycobacterial Infections Market size to grow by USD 4.33 billion from 2023 to 2028, North America to account for 40% of market growth- Technavio

Key Facts

View a Free PDF Sample Report Nontuberculous Mycobacterial Infections Market: Market Dynamics Key Driver The escalating prevalence of Nontuberculous Mycobacterial Infections (NTM), including Mycobacterium avium complex (MAC), Mycobacterium abscessus, Mycobacterium kansasii, Mycobacterium fortuitum, Mycobacterium chelonae, Mycobacterium xenopi, Mycobacterium malmoense, Mycobacterium intracellulare, and Mycobacterium genavense, stands as the primary driver boosting market expansion.
Related Reports: The upper respiratory tract infection treatment market size is estimated to grow by USD 2,661.15 million at a CAGR of 4.21% between 2023 and 2028.
- CAGR of the market during the forecast period * Detailed information on factors that will drive the growth of the nontuberculous mycobacterial infections market between 2023 and 2028.
- Precise estimation of the nontuberculous mycobacterial infections market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the nontuberculous mycobacterial infections market across North America, Europe, Asia, and ROW A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of nontuberculous mycobacterial infections market companies.